Literature DB >> 18982160

Evidence that cytokines play a role in rheumatoid arthritis.

Fionula M Brennan1, Iain B McInnes.   

Abstract

A large number of cytokines are active in the joints of patients with rheumatoid arthritis (RA). It is now clear that these cytokines play a fundamental role in the processes that cause inflammation, articular destruction, and the comorbidities associated with RA. Following the success of TNF-alpha blockade as a treatment for RA, other cytokines now offer alternative targets for therapeutic intervention or might be useful as predictive biomarkers of disease. In this Review, we discuss the biologic contribution and therapeutic potential of the major cytokine families to RA pathology, focusing on molecules contained within the TNF-alpha, IL-1, IL-6, IL-23, and IL-2 families.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18982160      PMCID: PMC2575731          DOI: 10.1172/JCI36389

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  123 in total

1.  Interleukin-15 mediates T cell-dependent regulation of tumor necrosis factor-alpha production in rheumatoid arthritis.

Authors:  I B McInnes; B P Leung; R D Sturrock; M Field; F Y Liew
Journal:  Nat Med       Date:  1997-02       Impact factor: 53.440

Review 2.  Role of cytokines in rheumatoid arthritis.

Authors:  M Feldmann; F M Brennan; R N Maini
Journal:  Annu Rev Immunol       Date:  1996       Impact factor: 28.527

3.  Amelioration of established murine collagen-induced arthritis with anti-IL-1 treatment.

Authors:  W B van den Berg; L A Joosten; M Helsen; F A van de Loo
Journal:  Clin Exp Immunol       Date:  1994-02       Impact factor: 4.330

4.  Modulation of proinflammatory cytokine release in rheumatoid synovial membrane cell cultures. Comparison of monoclonal anti TNF-alpha antibody with the interleukin-1 receptor antagonist.

Authors:  D M Butler; R N Maini; M Feldmann; F M Brennan
Journal:  Eur Cytokine Netw       Date:  1995 Jul-Dec       Impact factor: 2.737

5.  Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha.

Authors:  M J Elliott; R N Maini; M Feldmann; A Long-Fox; P Charles; P Katsikis; F M Brennan; J Walker; H Bijl; J Ghrayeb
Journal:  Arthritis Rheum       Date:  1993-12

6.  Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis.

Authors:  M J Elliott; R N Maini; M Feldmann; J R Kalden; C Antoni; J S Smolen; B Leeb; F C Breedveld; J D Macfarlane; H Bijl
Journal:  Lancet       Date:  1994-10-22       Impact factor: 79.321

7.  Administration of interleukin 12 in combination with type II collagen induces severe arthritis in DBA/1 mice.

Authors:  T Germann; J Szeliga; H Hess; S Störkel; F J Podlaski; M K Gately; E Schmitt; E Rüde
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-23       Impact factor: 11.205

8.  The role of interleukin-15 in T-cell migration and activation in rheumatoid arthritis.

Authors:  I B McInnes; J al-Mughales; M Field; B P Leung; F P Huang; R Dixon; R D Sturrock; P C Wilkinson; F Y Liew
Journal:  Nat Med       Date:  1996-02       Impact factor: 53.440

9.  Biphasic effect of interferon-gamma in murine collagen-induced arthritis.

Authors:  M C Boissier; G Chiocchia; N Bessis; J Hajnal; G Garotta; F Nicoletti; C Fournier
Journal:  Eur J Immunol       Date:  1995-05       Impact factor: 5.532

10.  Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells.

Authors:  R Manetti; P Parronchi; M G Giudizi; M P Piccinni; E Maggi; G Trinchieri; S Romagnani
Journal:  J Exp Med       Date:  1993-04-01       Impact factor: 14.307

View more
  359 in total

1.  The immunoglobulin D Fc receptor expressed on fibroblast-like synoviocytes from patients with rheumatoid arthritis contributes to the cell activation.

Authors:  Yu-Jing Wu; Wen-Sheng Chen; Heng-Shi Chen; Xing Dai; Jin Dong; Ying Wang; Ling-Ling Zhang; Yan Chang; Qiong Huang; Xiao-Yi Jia; Wei Wei
Journal:  Acta Pharmacol Sin       Date:  2017-08-03       Impact factor: 6.150

Review 2.  A cytokine-centric view of the pathogenesis and treatment of autoimmune arthritis.

Authors:  Brian Astry; Erin Harberts; Kamal D Moudgil
Journal:  J Interferon Cytokine Res       Date:  2011-12       Impact factor: 2.607

3.  Treatment for Helicobacter pylori infection and risk of Parkinson's disease in Denmark.

Authors:  H H Nielsen; J Qiu; S Friis; L Wermuth; B Ritz
Journal:  Eur J Neurol       Date:  2012-01-17       Impact factor: 6.089

4.  "Old drugs" for the treatment of rheumatoid arthritis: will the cholinergic anti-inflammatory pathway and anti-nociceptive pathway work?

Authors:  Xiaohua Pan; Xiaowei Yu; Ling Qin; Peng Zhang
Journal:  Inflamm Res       Date:  2010-09-17       Impact factor: 4.575

5.  Preclinical safety evaluation of recombinant adeno-associated virus 2 vector encoding human tumor necrosis factor receptor-immunoglobulin Fc fusion gene.

Authors:  Xiaobing Zhou; Lianzhong Shen; Li Liu; Chao Wang; Weihong Qi; Aizhi Zhao; Xiaobing Wu; Bo Li
Journal:  Hum Vaccin Immunother       Date:  2016-03-03       Impact factor: 3.452

6.  Association between IL-33 and other inflammatory factors in patients with rheumatoid arthritis and in fibroblast-like synoviocytes in vitro.

Authors:  Jing Wu; Qiang Li; Jiaxin Deng; Jin-Jun Zhao; Qing-Hong Yu
Journal:  Exp Ther Med       Date:  2020-12-18       Impact factor: 2.447

7.  Computational Analysis Supports IL-17A as a Central Driver of Neutrophil Extracellular Trap-Mediated Injury in Liver Ischemia Reperfusion.

Authors:  Samer Tohme; Hamza O Yazdani; Vikas Sud; Patricia Loughran; Hai Huang; Ruben Zamora; Richard L Simmons; Yoram Vodovotz; Allan Tsung
Journal:  J Immunol       Date:  2018-11-30       Impact factor: 5.422

8.  Peripheral soluble epoxide hydrolase inhibition reduces hypernociception and inflammation in albumin-induced arthritis in temporomandibular joint of rats.

Authors:  Juliana Maia Teixeira; Henrique Ballassini Abdalla; Rosanna Tarkany Basting; Bruce D Hammock; Marcelo Henrique Napimoga; Juliana Trindade Clemente-Napimoga
Journal:  Int Immunopharmacol       Date:  2020-07-28       Impact factor: 4.932

9.  NLRP3 inflammasome activation contributes to the pathogenesis of rheumatoid arthritis.

Authors:  C Guo; R Fu; S Wang; Y Huang; X Li; M Zhou; J Zhao; N Yang
Journal:  Clin Exp Immunol       Date:  2018-09-16       Impact factor: 4.330

Review 10.  Immunomodulation of autoimmune arthritis by pro-inflammatory cytokines.

Authors:  Eugene Y Kim; Kamal D Moudgil
Journal:  Cytokine       Date:  2017-04-25       Impact factor: 3.861

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.